Annual Shareholders Equity
$502.75 M
+$156.21 M+45.08%
December 31, 2024
Summary
- As of March 8, 2025, DAWN annual stockholders equity is $502.75 million, with the most recent change of +$156.21 million (+45.08%) on December 31, 2024.
- During the last 3 years, DAWN annual shareholders equity has risen by +$221.60 million (+78.82%).
- DAWN annual shareholders equity is now at all-time high.
Performance
DAWN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$502.75 M
-$52.71 M-9.49%
December 31, 2024
Summary
- As of March 8, 2025, DAWN quarterly stockholders equity is $502.75 million, with the most recent change of -$52.71 million (-9.49%) on December 31, 2024.
- Over the past year, DAWN quarterly shareholders equity has dropped by -$52.71 million (-9.49%).
- DAWN quarterly shareholders equity is now -9.49% below its all-time high of $555.46 million, reached on September 30, 2024.
Performance
DAWN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
DAWN Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +45.1% | -9.5% |
| 3 y3 years | +78.8% | -9.5% |
| 5 y5 years | +4810.5% | -9.5% |
DAWN Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +78.8% | -9.5% | +93.7% |
| 5 y | 5-year | at high | +1027.5% | -9.5% | +830.2% |
| alltime | all time | at high | +1027.5% | -9.5% | +830.2% |
Day One Biopharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $502.75 M(+45.1%) | $502.75 M(-9.5%) |
| Sep 2024 | - | $555.46 M(+81.1%) |
| Jun 2024 | - | $306.73 M(+3.3%) |
| Mar 2024 | - | $296.81 M(-14.4%) |
| Dec 2023 | $346.54 M(+4.4%) | $346.54 M(-11.1%) |
| Sep 2023 | - | $389.63 M(-8.5%) |
| Jun 2023 | - | $426.05 M(+41.8%) |
| Mar 2023 | - | $300.42 M(-9.5%) |
| Dec 2022 | $332.04 M | $332.04 M(-8.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $363.08 M(-7.1%) |
| Jun 2022 | - | $390.63 M(+50.5%) |
| Mar 2022 | - | $259.60 M(-7.7%) |
| Dec 2021 | $281.15 M(-618.7%) | $281.15 M(-5.6%) |
| Sep 2021 | - | $297.67 M(-4.5%) |
| Jun 2021 | - | $311.76 M(-552.8%) |
| Mar 2021 | - | -$68.85 M(+27.0%) |
| Dec 2020 | -$54.20 M(+407.9%) | -$54.20 M |
| Dec 2019 | -$10.67 M | - |
FAQ
- What is Day One Biopharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals annual shareholders equity year-on-year change?
- What is Day One Biopharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals quarterly shareholders equity year-on-year change?
What is Day One Biopharmaceuticals annual stockholders equity?
The current annual shareholders equity of DAWN is $502.75 M
What is the all time high annual shareholders equity for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high annual stockholders equity is $502.75 M
What is Day One Biopharmaceuticals annual shareholders equity year-on-year change?
Over the past year, DAWN annual stockholders equity has changed by +$156.21 M (+45.08%)
What is Day One Biopharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of DAWN is $502.75 M
What is the all time high quarterly shareholders equity for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high quarterly stockholders equity is $555.46 M
What is Day One Biopharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, DAWN quarterly stockholders equity has changed by -$52.71 M (-9.49%)